Historical record - last NADAC effective date: 2/23/2022
Product Information
ENTECAVIR 0.5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.0765 per EA under NDC 65162044603. Its NADAC has been published 315 times since Mar 9, 2016.
FDA first approved this application on Nov 12, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Entecavir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162044603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/23/2022
Active Ingredients
ENTECAVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206652FDA Approved
11/12/2015
TE Code
AB
On Market Since
11/28/2014
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 0.5 MG TABLET has been published 315 times since Mar 9, 2016, and over the history we have for it it has declined 95.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0765 per EA |
|---|---|
| All-time high | $23.6432 (Mar 16, 2016) |
| All-time low | $0.8444 (Dec 22, 2021) |
| Median price | $1.9269 |
| Average price | $5.0367 |
| Largest weekly change | -38.7% (Mar 17, 2021) |
| Weeks tracked | 315 |
| Tracking since | Mar 9, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-16.5%
All
-95.4%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENTECAVIR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $1.0765 per EA (NDC 65162044603), effective Mar 16, 2022.
How has the price of ENTECAVIR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 95.4%. It has been tracked across 315 weekly CMS publications since Mar 9, 2016.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?
Since Mar 9, 2016, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.8444 (Dec 22, 2021) to a high of $23.6432 (Mar 16, 2016), with a median of $1.9269 per EA.
Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENTECAVIR 0.5 MG TABLET, is $0.2134 per EA — about 80% below ENTECAVIR 0.5 MG TABLET.
Who manufactures ENTECAVIR 0.5 MG TABLET?
ENTECAVIR 0.5 MG TABLET (NDC 65162044603) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.